COVID-19 and PTSD: Assessing the Pandemic’s Toll on Mental Health
As researchers and clinicians continue to grapple with the psychological fallout from COVID-19, a growing body of literature has examined the prevalence of post-traumatic stress disorder (PTSD) in the general public. Women’s Health Research at Yale and its collaborators published a study questioning how these estimates vary so greatly and if such wide swaths of the public can truly be suffering from pandemic-related PTSD.
WHRY Funds Study on Psychological Resilience in COVID-19 Health Care Providers
Women’s Health Research at Yale announced funding for a new collaborative study with researchers at Mt. Sinai Medical Hospital in New York on the personal and professional stressors and coping strategies of frontline health care providers confronting the COVID-19 pandemic
Helping Our Students Achieve ‘Post-Traumatic Growth’
At any point in time, 1 in 5 children under the age of 18 are in need of behavioral-health services, and 80 percent of those children do not have access to the care they need. These numbers are now higher. Since the end of March 2020, nationwide and around the world, behavioral-health visits to emergency rooms for issues including anxiety, depression, and suicidality among children have been climbing steadily.Source: Education Week
One year later, a new wave of pandemic health concerns
On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic. Within a week, millions went home to shelter in place for what they thought would be a few weeks, hoping that their sacrifice would stop the spread of the coronavirus. One year later, more than 500,000 U.S. residents have died from the coronavirus, while the nation also has grappled with racial injustice, a brutal election cycle and civil unrest.Source: American Psychological Association
Yale Researchers Find Genetic Clues to Troubling PTSD Symptom
Symptoms of post-traumatic stress disorder (PTSD) overlap with several other psychiatric disorders, but one specific symptom — repeated disturbing memories and flashbacks about a specific event — is a defining characteristic of debilitating PTSD.
Brain Biomarkers Identify Those at Risk of Severe PTSD Symptoms
Using sophisticated computational tools, researchers at Yale University and the Icahn School of Medicine have discovered biomarkers that may explain why symptoms of post-traumatic stress disorder (PTSD) can be so severe for some people and not for others.
Health and Healing for Our Veterans
Yale School of Medicine has a deep and multifaceted relationship with the West Haven VA that goes back 60 years. Veterans have access to highly specialized Yale Medicine doctors who provide care approaches and treatments that are difficult to find elsewhere.Source: Yale Medicine
Pain and modifiable risk factors among overweight veterans who seek to lose weight
Robin Masheb, PhD, Senior Research Scientist in Psychiatry and Director of the Veterans Initiative for Eating and Weight at the VA Connecticut Healthcare System, is the senior author of a paper published in Appetite that examines the relationship between pain and and modifiable risk factors among overweight veterans who seek to lose weight.
Sanacora speaks on panel that looks at new applications for designer drugs, including ketamine
Gerard Sanacora, MD, PhD, Professor of Psychiatry and Director of the Yale Depression Research Program, spoke on a panel May 30 in Arlington, Va., about new medical applications for common drugs of abuse.
What's in a name? Yale researchers track PTSD's many identities during war
Adam Chekroud, PhD, Assistant Professor of Psychiatry, and John H. Krystal, MD, Robert L. McNeil, Jr. Professor of Neuroscience and Chair of the Yale Department of Psychiatry, are authors of a new paper published in Chronic Stress that documents a war of words that has been fought over the naming of Posttraumatic stress disorder (PTSD) during and following times of war.